Quantum-Si (NASDAQ:QSI - Get Free Report) issued its earnings results on Monday. The company reported ($0.18) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.18), Zacks reports. Quantum-Si had a negative net margin of 3,968.84% and a negative return on equity of 36.96%.
Quantum-Si Stock Performance
Shares of QSI stock traded down $0.08 on Monday, hitting $1.30. The company's stock had a trading volume of 8,335,246 shares, compared to its average volume of 23,766,254. Quantum-Si has a fifty-two week low of $0.61 and a fifty-two week high of $5.77. The company has a market capitalization of $185.53 million, a PE ratio of -2.03 and a beta of 2.69. The stock's 50 day moving average is $2.23 and its 200-day moving average is $1.44.
Analyst Upgrades and Downgrades
QSI has been the subject of a number of recent analyst reports. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a "hold" rating for the company in a research report on Wednesday, November 13th. HC Wainwright restated a "buy" rating and issued a $5.50 price target on shares of Quantum-Si in a research note on Tuesday, January 14th. Finally, Alliance Global Partners assumed coverage on shares of Quantum-Si in a report on Friday, February 7th. They issued a "buy" rating and a $3.75 price objective on the stock.
View Our Latest Stock Report on QSI
Insider Buying and Selling at Quantum-Si
In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the company's stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the sale, the director now owns 1,250,000 shares of the company's stock, valued at approximately $4,175,000. This represents a 73.72 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 30.04% of the company's stock.
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
